Wai-Fung Cheong

Title: Innovations by Wai-Fung Cheong in Cardiovascular Treatments

Introduction

Wai-Fung Cheong is an accomplished inventor based in Los Altos, CA. He has made significant contributions to the field of cardiovascular treatments, particularly focusing on bioresorbable polymer stents. With a total of 2 patents, his work aims to improve the quality of life for patients suffering from various heart conditions.

Latest Patents

Cheong's latest patents include groundbreaking methods for treating coronary and peripheral artery disease in diabetic patients. His first patent describes the use of bioresorbable polymer scaffolds, which may include everolimus, to effectively treat these conditions. The second patent focuses on pediatric applications of bioabsorbable polymer stents for infants and children with congenital heart defects. This innovative approach aims to reduce or eliminate the adverse effects of congenital heart defects, providing palliative care when necessary.

Career Highlights

Wai-Fung Cheong is currently employed at Abbott Cardiovascular Systems, Inc., where he continues to develop and refine his innovative treatments. His work has garnered attention in the medical community, highlighting the importance of advancements in cardiovascular care.

Collaborations

Cheong collaborates with notable colleagues, including Krishnankutty Sudhir and Virginia Giddings, who contribute to the research and development of these life-saving technologies.

Conclusion

Wai-Fung Cheong's contributions to cardiovascular treatments through his patents and work at Abbott Cardiovascular Systems, Inc. demonstrate his commitment to improving patient outcomes. His innovative approaches in treating heart conditions are paving the way for future advancements in medical technology.